Related references
Note: Only part of the references are listed.Intravenous phenytoin: a retrospective analysis of Bayesian forecasting versus conventional dosing in patients
Andrea Tobler et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2013)
Clinical decision support of therapeutic drug monitoring of phenytoin: measured versus adjusted phenytoin plasma concentrations
Matthew D. Krasowski et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2012)
Influence of posture on pharmacokinetics
Christian Queckenberg et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Differences between the Measured and Calculated Free Serum Phenytoin Concentrations in Epileptic Patients
Ji-Man Hong et al.
YONSEI MEDICAL JOURNAL (2009)
Therapeutic Drug Monitoring of Phenytoin in Critically Ill Patients
Sandrina L. von Winckelmann et al.
PHARMACOTHERAPY (2008)
Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children
Gerhard K. Wolf et al.
PEDIATRIC CRITICAL CARE MEDICINE (2006)
Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients
Markus Joerger et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
Clinical utility of free drug monitoring
A Dasgupta
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2002)
Share Paper
